Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dimitri F Dimitriou Insider Profile
4 Followers
Dimitri F Dimitriou, Chief Executive Officer at ImmuPharma, holds 3.57M shares in ImmuPharma (Ticker: GB:IMM). Most recently, Dimitri F Dimitriou Bought 38,462p shares of ImmuPharma on Feb 05, 2016 for an estimated value of 10.00K.
Dimitri F Dimitriou has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Dimitri F Dimitriou's holdings
Insider Roles
Chief Executive Officer
Roles that Dimitri F Dimitriou holds in companies
Most Profitable Insider Trade
The most profitable trade made by Dimitri F Dimitriou
Dimitri F Dimitriou's Trading History
List of latest transactions for each holding click on a transaction to see Dimitri F Dimitriou's performance on stock
You May Also Like
Dimitri F Dimitriou insider profile FAQ
What is the percentage of profitable transactions made by Dimitri F Dimitriou?
The percentage of profitable transactions made by Dimitri F Dimitriou is ―.
What is the average return per transaction made by Dimitri F Dimitriou?
The average return per transaction made by Dimitri F Dimitriou is ―.
What stocks does Dimitri F Dimitriou hold?
Dimitri F Dimitriou holds: GB:IMM stocks.
What was Dimitri F Dimitriou’s latest transaction?
Dimitri F Dimitriou latest transaction was an Informative Buy of 10.00K.
What was Dimitri F Dimitriou's most profitable transaction?
Dimitri F Dimitriou’s most profitable transaction was an Informative Buy of GB:IMM stock on February 5, 2016. The return on the trade was 115.60%.
What is Dimitri F Dimitriou's role in ImmuPharma?
Dimitri F Dimitriou's role in ImmuPharma is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.